Revusiran is a 1st-generation short interfering RNA, which directed against transthyretin (TTR) mRNA. Revusiran can be used for transthyretin (TTR)-mediated amyloidosis research.
* Please kindly note that our products are not to be used for therapeutic purposes and cannot be sold to patients.
